María Fernanda Guerra Veloz

Author

Hospital Universitario Virgen Macarena ORCID

Also Known As

Dina Chaaro Benallal, M F Guerra Veloz, M. F. Guerra Veloz, Maria Fernanda Guerra Veloz, María Fernanda Guerra Veloz, María Fernanda Guerra-Veloz

Publications

436

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Virgen Macarena Hospital Universitario Virgen del Rocío Hospital General Universitario de Ciudad Real Hospital Juan Ramón Jiménez Hospital Universitari i Politècnic La Fe

About

María Fernanda Guerra Veloz is an author at Hospital Universitario Virgen Macarena specializing in colorectal surgery, medicine, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	150
2	Gastroenterology	1	1	150
3	Colorectal Surgery	1	1	150
4	Radiology	1	1	150
5	Surgery	1	1	150

María Fernanda Guerra Veloz

Publications

350

Citations

H-Index

Page 1

	Year	Citations
Clip Closure After Resection of Large Colorectal Lesions With Substantial Risk of Bleeding Eduardo Albéniz, Marco Antonio Álvarez, Jorge C. Espinós, Gastroenterology Substantial RiskColorectal SurgeryLarge Colorectal LesionsGastroenterologyOpen Procedure	2019	150
Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months Federico Argüelles‐Arias, María Fernanda Guerra Veloz, Raúl Perea Amarillo, Digestive Diseases and Sciences	2017	44
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results Federico Argüelles‐Arias, María Fernanda Guerra Veloz, Raúl Perea Amarillo, European Journal of Gastroenterology & Hepatology	2017	42
Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel Disease María Chaparro, Ana Garre, María Fernanda Guerra Veloz, Journal of Crohn s and Colitis	2019	30
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months María Fernanda Guerra Veloz, Juan María Vázquez Morón, María Belvis Jiménez, Revista Española de Enfermedades Digestivas	2018	18
Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data María Fernanda Guerra Veloz, María Belvis Jiménez, Teresa Valdés Delgado, Therapeutic Advances in Gastroenterology	2019	18
Loss of efficacy and safety of the switch from infliximab original to infliximab biosimilar (CT-P13) in patients with inflammatory bowel disease María Fernanda Guerra Veloz, Federico Argüelles‐Arias, Luisa Castro Laria, World Journal of Gastroenterology	2018	17
LIVER MANIFESTATIONS IN COVID-19 AND THE INFLUENCE OF PRE-EXISTING LIVER DISEASE IN THE COURSE OF THE INFECTION María Fernanda Guerra Veloz, P. Ruíz, Maria Jose Rios Villegas, Revista Española de Enfermedades Digestivas	2020	16
HCV microelimination strategies: An interventional study in diagnosed patients without access to the system María Fernanda Guerra Veloz, Pilar Del Pino Bellido, P. Ruíz, Liver International	2021	15

Page 1